Perspectives of healthcare providers on implementation of long?acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation?effectiveness study (CUSTOMIZE)

MLA

Czarnogorski, Maggie, et al. “Perspectives of Healthcare Providers on Implementation of Long?Acting Cabotegravir plus Rilpivirine in US Healthcare Settings from a Hybrid III Implementation?Effectiveness Study (CUSTOMIZE).” Journal of the International AIDS Society, vol. 25, no. 9, Sept. 2022. EBSCOhost, https://doi.org/10.1002/jia2.26003.

APA

Czarnogorski, M., Garris, C. P., Dalessandro, M., D’ Amico, R., Nwafor, T., Williams, W., Merrill, D., Wang, Y., Stassek, L., Wohlfeiler, M. B., Sinclair, G. I., Mena, L. A., Thedinger, B., Flamm, J. A., Benson, P., & Spreen, W. R. (2022). Perspectives of healthcare providers on implementation of long?acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation?effectiveness study (CUSTOMIZE). Journal of the International AIDS Society, 25(9). https://doi.org/10.1002/jia2.26003

Chicago

Czarnogorski, Maggie, Cindy P. Garris, Marybeth Dalessandro, Ronald D’ Amico, Toyin Nwafor, Will Williams, Deanna Merrill, et al. 2022. “Perspectives of Healthcare Providers on Implementation of Long?Acting Cabotegravir plus Rilpivirine in US Healthcare Settings from a Hybrid III Implementation?Effectiveness Study (CUSTOMIZE).” Journal of the International AIDS Society 25 (9). doi:10.1002/jia2.26003.